Description
KLOW represents a multi-component peptide research formulation combining GHK-Cu (copper peptide), BPC-157 (pentadecapeptide), Thymosin beta-4(TB-500) (43-amino acid polypeptide), and KPV (tripeptide) in a synergistic research blend. It is available in kits of three, five and 10 vials.


Reviews
There are no reviews yet.